nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoniazid—CYP2A6—Methoxsalen—hematologic cancer	0.0359	0.0486	CbGbCtD
Isoniazid—CYP1A2—Anagrelide—hematologic cancer	0.0307	0.0415	CbGbCtD
Isoniazid—CYP2A6—Ifosfamide—hematologic cancer	0.0262	0.0354	CbGbCtD
Isoniazid—CYP2E1—Thalidomide—hematologic cancer	0.0196	0.0266	CbGbCtD
Isoniazid—CYP2C9—Bexarotene—hematologic cancer	0.0192	0.0259	CbGbCtD
Isoniazid—CYP2A6—Prednisolone—hematologic cancer	0.0175	0.0236	CbGbCtD
Isoniazid—CYP2E1—Dacarbazine—hematologic cancer	0.0169	0.0228	CbGbCtD
Isoniazid—CYP2C8—Bortezomib—hematologic cancer	0.0168	0.0228	CbGbCtD
Isoniazid—CYP2D6—Lomustine—hematologic cancer	0.0163	0.022	CbGbCtD
Isoniazid—CYP1A2—Carmustine—hematologic cancer	0.0161	0.0218	CbGbCtD
Isoniazid—CYP2C9—Idarubicin—hematologic cancer	0.0159	0.0215	CbGbCtD
Isoniazid—CYP2D6—Idarubicin—hematologic cancer	0.0145	0.0196	CbGbCtD
Isoniazid—CYP2C19—Bortezomib—hematologic cancer	0.0141	0.0191	CbGbCtD
Isoniazid—CYP1A2—Methoxsalen—hematologic cancer	0.0137	0.0185	CbGbCtD
Isoniazid—CYP2E1—Mitoxantrone—hematologic cancer	0.0131	0.0177	CbGbCtD
Isoniazid—CYP1A2—Bortezomib—hematologic cancer	0.013	0.0176	CbGbCtD
Isoniazid—CYP2C8—Ifosfamide—hematologic cancer	0.0129	0.0175	CbGbCtD
Isoniazid—CYP1A2—Daunorubicin—hematologic cancer	0.0125	0.0169	CbGbCtD
Isoniazid—CYP2D6—Hydroxyurea—hematologic cancer	0.0123	0.0167	CbGbCtD
Isoniazid—CYP2C19—Thalidomide—hematologic cancer	0.0123	0.0166	CbGbCtD
Isoniazid—CYP1A2—Alitretinoin—hematologic cancer	0.0122	0.0165	CbGbCtD
Isoniazid—CYP2C9—Bortezomib—hematologic cancer	0.0117	0.0159	CbGbCtD
Isoniazid—CYP2C19—Teniposide—hematologic cancer	0.0117	0.0159	CbGbCtD
Isoniazid—CYP1A2—Thalidomide—hematologic cancer	0.0114	0.0154	CbGbCtD
Isoniazid—CYP2C8—Nilotinib—hematologic cancer	0.0112	0.0152	CbGbCtD
Isoniazid—CYP3A4—Bexarotene—hematologic cancer	0.0111	0.0151	CbGbCtD
Isoniazid—CYP2C19—Ifosfamide—hematologic cancer	0.0108	0.0147	CbGbCtD
Isoniazid—CYP2D6—Bortezomib—hematologic cancer	0.0107	0.0145	CbGbCtD
Isoniazid—CYP3A4—Busulfan—hematologic cancer	0.0104	0.014	CbGbCtD
Isoniazid—CYP3A4—Lomustine—hematologic cancer	0.0104	0.014	CbGbCtD
Isoniazid—CYP2C19—Imatinib—hematologic cancer	0.0104	0.014	CbGbCtD
Isoniazid—CYP2A6—Dexamethasone—hematologic cancer	0.0103	0.0139	CbGbCtD
Isoniazid—CYP2C9—Thalidomide—hematologic cancer	0.0102	0.0138	CbGbCtD
Isoniazid—CYP1A2—Dacarbazine—hematologic cancer	0.00977	0.0132	CbGbCtD
Isoniazid—CYP2C9—Teniposide—hematologic cancer	0.00976	0.0132	CbGbCtD
Isoniazid—CYP1A2—Imatinib—hematologic cancer	0.00955	0.0129	CbGbCtD
Isoniazid—CYP3A4—Thiotepa—hematologic cancer	0.00923	0.0125	CbGbCtD
Isoniazid—CYP2C9—Ifosfamide—hematologic cancer	0.00901	0.0122	CbGbCtD
Isoniazid—CYP2C9—Imatinib—hematologic cancer	0.00861	0.0116	CbGbCtD
Isoniazid—CYP2E1—Etoposide—hematologic cancer	0.00826	0.0112	CbGbCtD
Isoniazid—CYP2D6—Imatinib—hematologic cancer	0.00787	0.0106	CbGbCtD
Isoniazid—CYP2C9—Nilotinib—hematologic cancer	0.00782	0.0106	CbGbCtD
Isoniazid—CYP1A2—Dasatinib—hematologic cancer	0.00767	0.0104	CbGbCtD
Isoniazid—CYP3A4—Methoxsalen—hematologic cancer	0.00718	0.00971	CbGbCtD
Isoniazid—CYP2D6—Nilotinib—hematologic cancer	0.00715	0.00967	CbGbCtD
Isoniazid—CYP2D6—Vinorelbine—hematologic cancer	0.00709	0.00959	CbGbCtD
Isoniazid—CYP3A4—Bortezomib—hematologic cancer	0.00683	0.00924	CbGbCtD
Isoniazid—CYP2C19—Prednisone—hematologic cancer	0.00682	0.00922	CbGbCtD
Isoniazid—CYP2E1—Dexamethasone—hematologic cancer	0.00679	0.00919	CbGbCtD
Isoniazid—CYP3A4—Daunorubicin—hematologic cancer	0.00653	0.00883	CbGbCtD
Isoniazid—CYP2C8—Etoposide—hematologic cancer	0.00617	0.00835	CbGbCtD
Isoniazid—CYP3A4—Cytarabine—hematologic cancer	0.00576	0.00779	CbGbCtD
Isoniazid—CYP3A4—Teniposide—hematologic cancer	0.00568	0.00768	CbGbCtD
Isoniazid—CYP3A4—Ifosfamide—hematologic cancer	0.00524	0.00708	CbGbCtD
Isoniazid—CYP2C8—Dexamethasone—hematologic cancer	0.00507	0.00686	CbGbCtD
Isoniazid—CYP3A4—Imatinib—hematologic cancer	0.005	0.00677	CbGbCtD
Isoniazid—CYP1A2—Etoposide—hematologic cancer	0.00478	0.00646	CbGbCtD
Isoniazid—CYP3A4—Ruxolitinib—hematologic cancer	0.00471	0.00637	CbGbCtD
Isoniazid—CYP3A4—Nilotinib—hematologic cancer	0.00455	0.00615	CbGbCtD
Isoniazid—CYP3A4—Vinorelbine—hematologic cancer	0.00451	0.0061	CbGbCtD
Isoniazid—CYP2C9—Cisplatin—hematologic cancer	0.00438	0.00593	CbGbCtD
Isoniazid—CYP2D6—Vinblastine—hematologic cancer	0.00437	0.00591	CbGbCtD
Isoniazid—CYP2C19—Dexamethasone—hematologic cancer	0.00426	0.00576	CbGbCtD
Isoniazid—CYP3A4—Triamcinolone—hematologic cancer	0.00412	0.00558	CbGbCtD
Isoniazid—CYP3A4—Dasatinib—hematologic cancer	0.00402	0.00543	CbGbCtD
Isoniazid—CYP3A4—Mitoxantrone—hematologic cancer	0.00397	0.00537	CbGbCtD
Isoniazid—CYP2C9—Dexamethasone—hematologic cancer	0.00354	0.00479	CbGbCtD
Isoniazid—CYP3A4—Betamethasone—hematologic cancer	0.00354	0.00478	CbGbCtD
Isoniazid—CYP3A4—Prednisolone—hematologic cancer	0.00349	0.00472	CbGbCtD
Isoniazid—CYP3A4—Prednisone—hematologic cancer	0.0033	0.00446	CbGbCtD
Isoniazid—CYP2D6—Dexamethasone—hematologic cancer	0.00324	0.00438	CbGbCtD
Isoniazid—CYP3A4—Irinotecan—hematologic cancer	0.00313	0.00423	CbGbCtD
Isoniazid—CYP3A4—Vinblastine—hematologic cancer	0.00278	0.00376	CbGbCtD
Isoniazid—CYP3A4—Vincristine—hematologic cancer	0.00273	0.00369	CbGbCtD
Isoniazid—CYP2D6—Doxorubicin—hematologic cancer	0.00269	0.00363	CbGbCtD
Isoniazid—CYP3A4—Etoposide—hematologic cancer	0.0025	0.00339	CbGbCtD
Isoniazid—CYP3A4—Dexamethasone—hematologic cancer	0.00206	0.00278	CbGbCtD
Isoniazid—CYP3A4—Doxorubicin—hematologic cancer	0.00171	0.00231	CbGbCtD
Isoniazid—Dyspepsia—Mitoxantrone—hematologic cancer	0.000104	0.000473	CcSEcCtD
Isoniazid—Feeling abnormal—Alitretinoin—hematologic cancer	0.000103	0.000472	CcSEcCtD
Isoniazid—Rash—Melphalan—hematologic cancer	0.000103	0.00047	CcSEcCtD
Isoniazid—Paraesthesia—Gemcitabine—hematologic cancer	0.000103	0.00047	CcSEcCtD
Isoniazid—Convulsion—Prednisolone—hematologic cancer	0.000103	0.000468	CcSEcCtD
Isoniazid—Asthenia—Vinorelbine—hematologic cancer	0.000102	0.000467	CcSEcCtD
Isoniazid—Decreased appetite—Irinotecan—hematologic cancer	0.000102	0.000467	CcSEcCtD
Isoniazid—Decreased appetite—Mitoxantrone—hematologic cancer	0.000102	0.000467	CcSEcCtD
Isoniazid—Feeling abnormal—Ifosfamide—hematologic cancer	0.000102	0.000466	CcSEcCtD
Isoniazid—Eosinophilia—Methotrexate—hematologic cancer	0.000102	0.000466	CcSEcCtD
Isoniazid—Nausea—Vinblastine—hematologic cancer	0.000102	0.000465	CcSEcCtD
Isoniazid—Anorexia—Cisplatin—hematologic cancer	0.000102	0.000465	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Irinotecan—hematologic cancer	0.000102	0.000464	CcSEcCtD
Isoniazid—Fatigue—Mitoxantrone—hematologic cancer	0.000102	0.000463	CcSEcCtD
Isoniazid—Fatigue—Irinotecan—hematologic cancer	0.000102	0.000463	CcSEcCtD
Isoniazid—Vomiting—Lenalidomide—hematologic cancer	0.000101	0.000461	CcSEcCtD
Isoniazid—Ill-defined disorder—Triamcinolone—hematologic cancer	0.000101	0.000461	CcSEcCtD
Isoniazid—Discomfort—Etoposide—hematologic cancer	0.000101	0.00046	CcSEcCtD
Isoniazid—Hypersensitivity—Thiotepa—hematologic cancer	0.0001	0.000458	CcSEcCtD
Isoniazid—Rash—Lenalidomide—hematologic cancer	0.0001	0.000457	CcSEcCtD
Isoniazid—Body temperature increased—Carmustine—hematologic cancer	0.0001	0.000457	CcSEcCtD
Isoniazid—Decreased appetite—Gemcitabine—hematologic cancer	9.97e-05	0.000455	CcSEcCtD
Isoniazid—Vomiting—Hydroxyurea—hematologic cancer	9.96e-05	0.000454	CcSEcCtD
Isoniazid—Discomfort—Prednisolone—hematologic cancer	9.96e-05	0.000454	CcSEcCtD
Isoniazid—Body temperature increased—Alitretinoin—hematologic cancer	9.92e-05	0.000452	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Gemcitabine—hematologic cancer	9.91e-05	0.000452	CcSEcCtD
Isoniazid—Fatigue—Gemcitabine—hematologic cancer	9.89e-05	0.000451	CcSEcCtD
Isoniazid—Rash—Hydroxyurea—hematologic cancer	9.88e-05	0.000451	CcSEcCtD
Isoniazid—Malaise—Triamcinolone—hematologic cancer	9.82e-05	0.000448	CcSEcCtD
Isoniazid—Body temperature increased—Ifosfamide—hematologic cancer	9.81e-05	0.000447	CcSEcCtD
Isoniazid—Asthenia—Thiotepa—hematologic cancer	9.79e-05	0.000446	CcSEcCtD
Isoniazid—Hypersensitivity—Thalidomide—hematologic cancer	9.72e-05	0.000443	CcSEcCtD
Isoniazid—Nausea—Melphalan—hematologic cancer	9.71e-05	0.000443	CcSEcCtD
Isoniazid—Feeling abnormal—Mitoxantrone—hematologic cancer	9.71e-05	0.000443	CcSEcCtD
Isoniazid—Feeling abnormal—Irinotecan—hematologic cancer	9.71e-05	0.000443	CcSEcCtD
Isoniazid—Paraesthesia—Cisplatin—hematologic cancer	9.6e-05	0.000438	CcSEcCtD
Isoniazid—Thrombocytopenia—Etoposide—hematologic cancer	9.59e-05	0.000437	CcSEcCtD
Isoniazid—Eosinophilia—Epirubicin—hematologic cancer	9.56e-05	0.000436	CcSEcCtD
Isoniazid—Body temperature increased—Vincristine—hematologic cancer	9.56e-05	0.000436	CcSEcCtD
Isoniazid—Asthenia—Thalidomide—hematologic cancer	9.46e-05	0.000432	CcSEcCtD
Isoniazid—Feeling abnormal—Gemcitabine—hematologic cancer	9.45e-05	0.000431	CcSEcCtD
Isoniazid—Nausea—Lenalidomide—hematologic cancer	9.44e-05	0.00043	CcSEcCtD
Isoniazid—Convulsion—Triamcinolone—hematologic cancer	9.43e-05	0.00043	CcSEcCtD
Isoniazid—Anorexia—Etoposide—hematologic cancer	9.34e-05	0.000426	CcSEcCtD
Isoniazid—Hypersensitivity—Carmustine—hematologic cancer	9.33e-05	0.000426	CcSEcCtD
Isoniazid—Body temperature increased—Irinotecan—hematologic cancer	9.31e-05	0.000425	CcSEcCtD
Isoniazid—Body temperature increased—Mitoxantrone—hematologic cancer	9.31e-05	0.000425	CcSEcCtD
Isoniazid—Nausea—Hydroxyurea—hematologic cancer	9.31e-05	0.000424	CcSEcCtD
Isoniazid—Vomiting—Bortezomib—hematologic cancer	9.3e-05	0.000424	CcSEcCtD
Isoniazid—Decreased appetite—Cisplatin—hematologic cancer	9.3e-05	0.000424	CcSEcCtD
Isoniazid—Hypersensitivity—Alitretinoin—hematologic cancer	9.25e-05	0.000422	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Cisplatin—hematologic cancer	9.23e-05	0.000421	CcSEcCtD
Isoniazid—Vomiting—Bleomycin—hematologic cancer	9.23e-05	0.000421	CcSEcCtD
Isoniazid—Rash—Bortezomib—hematologic cancer	9.22e-05	0.00042	CcSEcCtD
Isoniazid—Ill-defined disorder—Dexamethasone—hematologic cancer	9.17e-05	0.000418	CcSEcCtD
Isoniazid—Ill-defined disorder—Betamethasone—hematologic cancer	9.17e-05	0.000418	CcSEcCtD
Isoniazid—Discomfort—Triamcinolone—hematologic cancer	9.16e-05	0.000418	CcSEcCtD
Isoniazid—Rash—Bleomycin—hematologic cancer	9.15e-05	0.000417	CcSEcCtD
Isoniazid—Hypersensitivity—Ifosfamide—hematologic cancer	9.14e-05	0.000417	CcSEcCtD
Isoniazid—Asthenia—Carmustine—hematologic cancer	9.09e-05	0.000414	CcSEcCtD
Isoniazid—Vomiting—Vinorelbine—hematologic cancer	9.08e-05	0.000414	CcSEcCtD
Isoniazid—Body temperature increased—Gemcitabine—hematologic cancer	9.07e-05	0.000414	CcSEcCtD
Isoniazid—Asthenia—Alitretinoin—hematologic cancer	9e-05	0.000411	CcSEcCtD
Isoniazid—Rash—Vinorelbine—hematologic cancer	9e-05	0.000411	CcSEcCtD
Isoniazid—Hypersensitivity—Vincristine—hematologic cancer	8.91e-05	0.000406	CcSEcCtD
Isoniazid—Malaise—Betamethasone—hematologic cancer	8.91e-05	0.000406	CcSEcCtD
Isoniazid—Malaise—Dexamethasone—hematologic cancer	8.91e-05	0.000406	CcSEcCtD
Isoniazid—Asthenia—Ifosfamide—hematologic cancer	8.9e-05	0.000406	CcSEcCtD
Isoniazid—Eosinophilia—Doxorubicin—hematologic cancer	8.85e-05	0.000403	CcSEcCtD
Isoniazid—Feeling abnormal—Cisplatin—hematologic cancer	8.81e-05	0.000402	CcSEcCtD
Isoniazid—Paraesthesia—Etoposide—hematologic cancer	8.8e-05	0.000401	CcSEcCtD
Isoniazid—Hyperglycaemia—Epirubicin—hematologic cancer	8.71e-05	0.000397	CcSEcCtD
Isoniazid—Nausea—Bortezomib—hematologic cancer	8.69e-05	0.000396	CcSEcCtD
Isoniazid—Hypersensitivity—Irinotecan—hematologic cancer	8.68e-05	0.000396	CcSEcCtD
Isoniazid—Hypersensitivity—Mitoxantrone—hematologic cancer	8.68e-05	0.000396	CcSEcCtD
Isoniazid—Asthenia—Vincristine—hematologic cancer	8.68e-05	0.000396	CcSEcCtD
Isoniazid—Paraesthesia—Prednisolone—hematologic cancer	8.68e-05	0.000396	CcSEcCtD
Isoniazid—Vomiting—Thiotepa—hematologic cancer	8.67e-05	0.000395	CcSEcCtD
Isoniazid—Nausea—Bleomycin—hematologic cancer	8.62e-05	0.000393	CcSEcCtD
Isoniazid—Rash—Thiotepa—hematologic cancer	8.6e-05	0.000392	CcSEcCtD
Isoniazid—Agranulocytosis—Methotrexate—hematologic cancer	8.59e-05	0.000391	CcSEcCtD
Isoniazid—Convulsion—Dexamethasone—hematologic cancer	8.56e-05	0.00039	CcSEcCtD
Isoniazid—Convulsion—Betamethasone—hematologic cancer	8.56e-05	0.00039	CcSEcCtD
Isoniazid—Decreased appetite—Etoposide—hematologic cancer	8.52e-05	0.000388	CcSEcCtD
Isoniazid—Nausea—Vinorelbine—hematologic cancer	8.48e-05	0.000387	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Etoposide—hematologic cancer	8.46e-05	0.000386	CcSEcCtD
Isoniazid—Body temperature increased—Cisplatin—hematologic cancer	8.45e-05	0.000385	CcSEcCtD
Isoniazid—Asthenia—Irinotecan—hematologic cancer	8.45e-05	0.000385	CcSEcCtD
Isoniazid—Asthenia—Mitoxantrone—hematologic cancer	8.45e-05	0.000385	CcSEcCtD
Isoniazid—Fatigue—Etoposide—hematologic cancer	8.45e-05	0.000385	CcSEcCtD
Isoniazid—Neuropathy peripheral—Epirubicin—hematologic cancer	8.44e-05	0.000385	CcSEcCtD
Isoniazid—Jaundice—Epirubicin—hematologic cancer	8.39e-05	0.000383	CcSEcCtD
Isoniazid—Vomiting—Thalidomide—hematologic cancer	8.39e-05	0.000382	CcSEcCtD
Isoniazid—Rash—Thalidomide—hematologic cancer	8.32e-05	0.000379	CcSEcCtD
Isoniazid—Discomfort—Dexamethasone—hematologic cancer	8.31e-05	0.000379	CcSEcCtD
Isoniazid—Discomfort—Betamethasone—hematologic cancer	8.31e-05	0.000379	CcSEcCtD
Isoniazid—Hepatitis—Methotrexate—hematologic cancer	8.26e-05	0.000377	CcSEcCtD
Isoniazid—Asthenia—Gemcitabine—hematologic cancer	8.23e-05	0.000375	CcSEcCtD
Isoniazid—Nausea—Thiotepa—hematologic cancer	8.1e-05	0.000369	CcSEcCtD
Isoniazid—Feeling abnormal—Etoposide—hematologic cancer	8.07e-05	0.000368	CcSEcCtD
Isoniazid—Hyperglycaemia—Doxorubicin—hematologic cancer	8.06e-05	0.000367	CcSEcCtD
Isoniazid—Vomiting—Carmustine—hematologic cancer	8.06e-05	0.000367	CcSEcCtD
Isoniazid—Agranulocytosis—Epirubicin—hematologic cancer	8.04e-05	0.000366	CcSEcCtD
Isoniazid—Rash—Carmustine—hematologic cancer	7.99e-05	0.000364	CcSEcCtD
Isoniazid—Ill-defined disorder—Prednisone—hematologic cancer	7.98e-05	0.000364	CcSEcCtD
Isoniazid—Vomiting—Alitretinoin—hematologic cancer	7.98e-05	0.000364	CcSEcCtD
Isoniazid—Paraesthesia—Triamcinolone—hematologic cancer	7.98e-05	0.000364	CcSEcCtD
Isoniazid—Feeling abnormal—Prednisolone—hematologic cancer	7.96e-05	0.000363	CcSEcCtD
Isoniazid—Rash—Alitretinoin—hematologic cancer	7.91e-05	0.000361	CcSEcCtD
Isoniazid—Thrombocytopenia—Betamethasone—hematologic cancer	7.89e-05	0.00036	CcSEcCtD
Isoniazid—Thrombocytopenia—Dexamethasone—hematologic cancer	7.89e-05	0.00036	CcSEcCtD
Isoniazid—Vomiting—Ifosfamide—hematologic cancer	7.89e-05	0.00036	CcSEcCtD
Isoniazid—Hypersensitivity—Cisplatin—hematologic cancer	7.88e-05	0.000359	CcSEcCtD
Isoniazid—Nausea—Thalidomide—hematologic cancer	7.84e-05	0.000357	CcSEcCtD
Isoniazid—Dyspepsia—Triamcinolone—hematologic cancer	7.82e-05	0.000357	CcSEcCtD
Isoniazid—Rash—Ifosfamide—hematologic cancer	7.82e-05	0.000357	CcSEcCtD
Isoniazid—Neuropathy peripheral—Doxorubicin—hematologic cancer	7.81e-05	0.000356	CcSEcCtD
Isoniazid—Jaundice—Doxorubicin—hematologic cancer	7.77e-05	0.000354	CcSEcCtD
Isoniazid—Malaise—Prednisone—hematologic cancer	7.76e-05	0.000354	CcSEcCtD
Isoniazid—Body temperature increased—Etoposide—hematologic cancer	7.74e-05	0.000353	CcSEcCtD
Isoniazid—Hepatitis—Epirubicin—hematologic cancer	7.73e-05	0.000352	CcSEcCtD
Isoniazid—Vomiting—Vincristine—hematologic cancer	7.69e-05	0.000351	CcSEcCtD
Isoniazid—Anorexia—Dexamethasone—hematologic cancer	7.69e-05	0.00035	CcSEcCtD
Isoniazid—Anorexia—Betamethasone—hematologic cancer	7.69e-05	0.00035	CcSEcCtD
Isoniazid—Asthenia—Cisplatin—hematologic cancer	7.67e-05	0.00035	CcSEcCtD
Isoniazid—Fatigue—Triamcinolone—hematologic cancer	7.66e-05	0.000349	CcSEcCtD
Isoniazid—Rash—Vincristine—hematologic cancer	7.63e-05	0.000348	CcSEcCtD
Isoniazid—Nausea—Carmustine—hematologic cancer	7.53e-05	0.000343	CcSEcCtD
Isoniazid—Vomiting—Mitoxantrone—hematologic cancer	7.49e-05	0.000341	CcSEcCtD
Isoniazid—Vomiting—Irinotecan—hematologic cancer	7.49e-05	0.000341	CcSEcCtD
Isoniazid—Nausea—Alitretinoin—hematologic cancer	7.46e-05	0.00034	CcSEcCtD
Isoniazid—Convulsion—Prednisone—hematologic cancer	7.45e-05	0.00034	CcSEcCtD
Isoniazid—Agranulocytosis—Doxorubicin—hematologic cancer	7.44e-05	0.000339	CcSEcCtD
Isoniazid—Rash—Irinotecan—hematologic cancer	7.43e-05	0.000339	CcSEcCtD
Isoniazid—Rash—Mitoxantrone—hematologic cancer	7.43e-05	0.000339	CcSEcCtD
Isoniazid—Nausea—Ifosfamide—hematologic cancer	7.37e-05	0.000336	CcSEcCtD
Isoniazid—Feeling abnormal—Triamcinolone—hematologic cancer	7.32e-05	0.000334	CcSEcCtD
Isoniazid—Vomiting—Gemcitabine—hematologic cancer	7.29e-05	0.000333	CcSEcCtD
Isoniazid—Paraesthesia—Dexamethasone—hematologic cancer	7.24e-05	0.00033	CcSEcCtD
Isoniazid—Paraesthesia—Betamethasone—hematologic cancer	7.24e-05	0.00033	CcSEcCtD
Isoniazid—Discomfort—Prednisone—hematologic cancer	7.24e-05	0.00033	CcSEcCtD
Isoniazid—Rash—Gemcitabine—hematologic cancer	7.23e-05	0.00033	CcSEcCtD
Isoniazid—Hypersensitivity—Etoposide—hematologic cancer	7.22e-05	0.000329	CcSEcCtD
Isoniazid—Nausea—Vincristine—hematologic cancer	7.18e-05	0.000328	CcSEcCtD
Isoniazid—Hepatitis—Doxorubicin—hematologic cancer	7.15e-05	0.000326	CcSEcCtD
Isoniazid—Hypersensitivity—Prednisolone—hematologic cancer	7.12e-05	0.000325	CcSEcCtD
Isoniazid—Dyspepsia—Dexamethasone—hematologic cancer	7.1e-05	0.000324	CcSEcCtD
Isoniazid—Dyspepsia—Betamethasone—hematologic cancer	7.1e-05	0.000324	CcSEcCtD
Isoniazid—Asthenia—Etoposide—hematologic cancer	7.03e-05	0.00032	CcSEcCtD
Isoniazid—Body temperature increased—Triamcinolone—hematologic cancer	7.02e-05	0.00032	CcSEcCtD
Isoniazid—Decreased appetite—Betamethasone—hematologic cancer	7.01e-05	0.00032	CcSEcCtD
Isoniazid—Decreased appetite—Dexamethasone—hematologic cancer	7.01e-05	0.00032	CcSEcCtD
Isoniazid—Nausea—Irinotecan—hematologic cancer	7e-05	0.000319	CcSEcCtD
Isoniazid—Nausea—Mitoxantrone—hematologic cancer	7e-05	0.000319	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Dexamethasone—hematologic cancer	6.96e-05	0.000317	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Betamethasone—hematologic cancer	6.96e-05	0.000317	CcSEcCtD
Isoniazid—Fatigue—Dexamethasone—hematologic cancer	6.95e-05	0.000317	CcSEcCtD
Isoniazid—Fatigue—Betamethasone—hematologic cancer	6.95e-05	0.000317	CcSEcCtD
Isoniazid—Nausea—Gemcitabine—hematologic cancer	6.81e-05	0.000311	CcSEcCtD
Isoniazid—Vomiting—Cisplatin—hematologic cancer	6.8e-05	0.00031	CcSEcCtD
Isoniazid—Rash—Cisplatin—hematologic cancer	6.74e-05	0.000307	CcSEcCtD
Isoniazid—Anorexia—Prednisone—hematologic cancer	6.69e-05	0.000305	CcSEcCtD
Isoniazid—Ill-defined disorder—Methotrexate—hematologic cancer	6.67e-05	0.000304	CcSEcCtD
Isoniazid—Feeling abnormal—Betamethasone—hematologic cancer	6.64e-05	0.000303	CcSEcCtD
Isoniazid—Feeling abnormal—Dexamethasone—hematologic cancer	6.64e-05	0.000303	CcSEcCtD
Isoniazid—Hypersensitivity—Triamcinolone—hematologic cancer	6.55e-05	0.000298	CcSEcCtD
Isoniazid—Malaise—Methotrexate—hematologic cancer	6.48e-05	0.000296	CcSEcCtD
Isoniazid—Asthenia—Triamcinolone—hematologic cancer	6.38e-05	0.000291	CcSEcCtD
Isoniazid—Body temperature increased—Betamethasone—hematologic cancer	6.37e-05	0.000291	CcSEcCtD
Isoniazid—Body temperature increased—Dexamethasone—hematologic cancer	6.37e-05	0.000291	CcSEcCtD
Isoniazid—Nausea—Cisplatin—hematologic cancer	6.35e-05	0.00029	CcSEcCtD
Isoniazid—Paraesthesia—Prednisone—hematologic cancer	6.31e-05	0.000287	CcSEcCtD
Isoniazid—Ill-defined disorder—Epirubicin—hematologic cancer	6.24e-05	0.000285	CcSEcCtD
Isoniazid—Convulsion—Methotrexate—hematologic cancer	6.23e-05	0.000284	CcSEcCtD
Isoniazid—Vomiting—Etoposide—hematologic cancer	6.23e-05	0.000284	CcSEcCtD
Isoniazid—Dyspepsia—Prednisone—hematologic cancer	6.18e-05	0.000282	CcSEcCtD
Isoniazid—Rash—Etoposide—hematologic cancer	6.18e-05	0.000282	CcSEcCtD
Isoniazid—Decreased appetite—Prednisone—hematologic cancer	6.1e-05	0.000278	CcSEcCtD
Isoniazid—Rash—Prednisolone—hematologic cancer	6.09e-05	0.000278	CcSEcCtD
Isoniazid—Malaise—Epirubicin—hematologic cancer	6.07e-05	0.000277	CcSEcCtD
Isoniazid—Fatigue—Prednisone—hematologic cancer	6.05e-05	0.000276	CcSEcCtD
Isoniazid—Discomfort—Methotrexate—hematologic cancer	6.05e-05	0.000276	CcSEcCtD
Isoniazid—Convulsion—Epirubicin—hematologic cancer	5.83e-05	0.000266	CcSEcCtD
Isoniazid—Nausea—Etoposide—hematologic cancer	5.82e-05	0.000265	CcSEcCtD
Isoniazid—Feeling abnormal—Prednisone—hematologic cancer	5.79e-05	0.000264	CcSEcCtD
Isoniazid—Asthenia—Betamethasone—hematologic cancer	5.78e-05	0.000264	CcSEcCtD
Isoniazid—Asthenia—Dexamethasone—hematologic cancer	5.78e-05	0.000264	CcSEcCtD
Isoniazid—Ill-defined disorder—Doxorubicin—hematologic cancer	5.78e-05	0.000263	CcSEcCtD
Isoniazid—Thrombocytopenia—Methotrexate—hematologic cancer	5.75e-05	0.000262	CcSEcCtD
Isoniazid—Nausea—Prednisolone—hematologic cancer	5.74e-05	0.000262	CcSEcCtD
Isoniazid—Discomfort—Epirubicin—hematologic cancer	5.66e-05	0.000258	CcSEcCtD
Isoniazid—Vomiting—Triamcinolone—hematologic cancer	5.65e-05	0.000258	CcSEcCtD
Isoniazid—Malaise—Doxorubicin—hematologic cancer	5.61e-05	0.000256	CcSEcCtD
Isoniazid—Rash—Triamcinolone—hematologic cancer	5.6e-05	0.000255	CcSEcCtD
Isoniazid—Anorexia—Methotrexate—hematologic cancer	5.59e-05	0.000255	CcSEcCtD
Isoniazid—Body temperature increased—Prednisone—hematologic cancer	5.55e-05	0.000253	CcSEcCtD
Isoniazid—Convulsion—Doxorubicin—hematologic cancer	5.39e-05	0.000246	CcSEcCtD
Isoniazid—Thrombocytopenia—Epirubicin—hematologic cancer	5.38e-05	0.000245	CcSEcCtD
Isoniazid—Nausea—Triamcinolone—hematologic cancer	5.28e-05	0.000241	CcSEcCtD
Isoniazid—Paraesthesia—Methotrexate—hematologic cancer	5.27e-05	0.00024	CcSEcCtD
Isoniazid—Discomfort—Doxorubicin—hematologic cancer	5.24e-05	0.000239	CcSEcCtD
Isoniazid—Anorexia—Epirubicin—hematologic cancer	5.23e-05	0.000239	CcSEcCtD
Isoniazid—Hypersensitivity—Prednisone—hematologic cancer	5.17e-05	0.000236	CcSEcCtD
Isoniazid—Dyspepsia—Methotrexate—hematologic cancer	5.17e-05	0.000236	CcSEcCtD
Isoniazid—Vomiting—Betamethasone—hematologic cancer	5.13e-05	0.000234	CcSEcCtD
Isoniazid—Vomiting—Dexamethasone—hematologic cancer	5.13e-05	0.000234	CcSEcCtD
Isoniazid—Decreased appetite—Methotrexate—hematologic cancer	5.1e-05	0.000233	CcSEcCtD
Isoniazid—Rash—Betamethasone—hematologic cancer	5.08e-05	0.000232	CcSEcCtD
Isoniazid—Rash—Dexamethasone—hematologic cancer	5.08e-05	0.000232	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Methotrexate—hematologic cancer	5.07e-05	0.000231	CcSEcCtD
Isoniazid—Fatigue—Methotrexate—hematologic cancer	5.06e-05	0.000231	CcSEcCtD
Isoniazid—Asthenia—Prednisone—hematologic cancer	5.04e-05	0.00023	CcSEcCtD
Isoniazid—Thrombocytopenia—Doxorubicin—hematologic cancer	4.98e-05	0.000227	CcSEcCtD
Isoniazid—Paraesthesia—Epirubicin—hematologic cancer	4.93e-05	0.000225	CcSEcCtD
Isoniazid—Anorexia—Doxorubicin—hematologic cancer	4.84e-05	0.000221	CcSEcCtD
Isoniazid—Feeling abnormal—Methotrexate—hematologic cancer	4.84e-05	0.00022	CcSEcCtD
Isoniazid—Dyspepsia—Epirubicin—hematologic cancer	4.83e-05	0.00022	CcSEcCtD
Isoniazid—Nausea—Betamethasone—hematologic cancer	4.79e-05	0.000218	CcSEcCtD
Isoniazid—Nausea—Dexamethasone—hematologic cancer	4.79e-05	0.000218	CcSEcCtD
Isoniazid—Decreased appetite—Epirubicin—hematologic cancer	4.77e-05	0.000218	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Epirubicin—hematologic cancer	4.74e-05	0.000216	CcSEcCtD
Isoniazid—Fatigue—Epirubicin—hematologic cancer	4.73e-05	0.000216	CcSEcCtD
Isoniazid—Body temperature increased—Methotrexate—hematologic cancer	4.64e-05	0.000212	CcSEcCtD
Isoniazid—Paraesthesia—Doxorubicin—hematologic cancer	4.56e-05	0.000208	CcSEcCtD
Isoniazid—Feeling abnormal—Epirubicin—hematologic cancer	4.53e-05	0.000206	CcSEcCtD
Isoniazid—Dyspepsia—Doxorubicin—hematologic cancer	4.47e-05	0.000204	CcSEcCtD
Isoniazid—Vomiting—Prednisone—hematologic cancer	4.46e-05	0.000204	CcSEcCtD
Isoniazid—Rash—Prednisone—hematologic cancer	4.43e-05	0.000202	CcSEcCtD
Isoniazid—Decreased appetite—Doxorubicin—hematologic cancer	4.42e-05	0.000201	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Doxorubicin—hematologic cancer	4.39e-05	0.0002	CcSEcCtD
Isoniazid—Fatigue—Doxorubicin—hematologic cancer	4.38e-05	0.0002	CcSEcCtD
Isoniazid—Body temperature increased—Epirubicin—hematologic cancer	4.34e-05	0.000198	CcSEcCtD
Isoniazid—Hypersensitivity—Methotrexate—hematologic cancer	4.32e-05	0.000197	CcSEcCtD
Isoniazid—Asthenia—Methotrexate—hematologic cancer	4.21e-05	0.000192	CcSEcCtD
Isoniazid—Feeling abnormal—Doxorubicin—hematologic cancer	4.19e-05	0.000191	CcSEcCtD
Isoniazid—Nausea—Prednisone—hematologic cancer	4.17e-05	0.00019	CcSEcCtD
Isoniazid—Hypersensitivity—Epirubicin—hematologic cancer	4.05e-05	0.000184	CcSEcCtD
Isoniazid—Body temperature increased—Doxorubicin—hematologic cancer	4.02e-05	0.000183	CcSEcCtD
Isoniazid—Asthenia—Epirubicin—hematologic cancer	3.94e-05	0.00018	CcSEcCtD
Isoniazid—Hypersensitivity—Doxorubicin—hematologic cancer	3.74e-05	0.000171	CcSEcCtD
Isoniazid—Vomiting—Methotrexate—hematologic cancer	3.73e-05	0.00017	CcSEcCtD
Isoniazid—Rash—Methotrexate—hematologic cancer	3.7e-05	0.000169	CcSEcCtD
Isoniazid—Asthenia—Doxorubicin—hematologic cancer	3.65e-05	0.000166	CcSEcCtD
Isoniazid—Vomiting—Epirubicin—hematologic cancer	3.49e-05	0.000159	CcSEcCtD
Isoniazid—Nausea—Methotrexate—hematologic cancer	3.49e-05	0.000159	CcSEcCtD
Isoniazid—Rash—Epirubicin—hematologic cancer	3.46e-05	0.000158	CcSEcCtD
Isoniazid—Nausea—Epirubicin—hematologic cancer	3.26e-05	0.000149	CcSEcCtD
Isoniazid—Vomiting—Doxorubicin—hematologic cancer	3.23e-05	0.000147	CcSEcCtD
Isoniazid—Rash—Doxorubicin—hematologic cancer	3.2e-05	0.000146	CcSEcCtD
Isoniazid—Nausea—Doxorubicin—hematologic cancer	3.02e-05	0.000138	CcSEcCtD
Isoniazid—CYP2C9—Metabolism—SLC22A1—hematologic cancer	6.53e-06	0.000158	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—NUP214—hematologic cancer	6.51e-06	0.000158	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—NCOR2—hematologic cancer	6.48e-06	0.000157	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.45e-06	0.000156	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—ALOX5—hematologic cancer	6.42e-06	0.000156	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—ABCG2—hematologic cancer	6.38e-06	0.000155	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—MTR—hematologic cancer	6.38e-06	0.000155	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—ALOX5—hematologic cancer	6.36e-06	0.000154	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.35e-06	0.000154	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—GSTM1—hematologic cancer	6.34e-06	0.000154	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—NCOR1—hematologic cancer	6.34e-06	0.000154	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.27e-06	0.000152	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—ENO2—hematologic cancer	6.26e-06	0.000152	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—NUP98—hematologic cancer	6.21e-06	0.000151	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—CYCS—hematologic cancer	6.19e-06	0.00015	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—IDH1—hematologic cancer	6.17e-06	0.00015	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—NUP98—hematologic cancer	6.16e-06	0.000149	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—HSP90AA1—hematologic cancer	6.15e-06	0.000149	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—TXN—hematologic cancer	6.1e-06	0.000148	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ABCC3—hematologic cancer	6.1e-06	0.000148	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—GSTO1—hematologic cancer	6.1e-06	0.000148	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—GSTT1—hematologic cancer	6.07e-06	0.000147	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—ADCY7—hematologic cancer	6.03e-06	0.000146	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—NCOA3—hematologic cancer	6.03e-06	0.000146	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.99e-06	0.000145	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—NUP214—hematologic cancer	5.99e-06	0.000145	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—ADCY7—hematologic cancer	5.98e-06	0.000145	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—NCOA3—hematologic cancer	5.98e-06	0.000145	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.98e-06	0.000145	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—SPHK1—hematologic cancer	5.97e-06	0.000145	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—FHL2—hematologic cancer	5.95e-06	0.000144	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—NUP214—hematologic cancer	5.94e-06	0.000144	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—SDC1—hematologic cancer	5.93e-06	0.000144	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.88e-06	0.000143	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—MTR—hematologic cancer	5.87e-06	0.000142	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—ABCG2—hematologic cancer	5.87e-06	0.000142	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—AGRN—hematologic cancer	5.84e-06	0.000142	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—ABCG2—hematologic cancer	5.82e-06	0.000141	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—MTR—hematologic cancer	5.82e-06	0.000141	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—ENO2—hematologic cancer	5.76e-06	0.00014	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—UGT1A1—hematologic cancer	5.73e-06	0.000139	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—ENO2—hematologic cancer	5.71e-06	0.000138	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.67e-06	0.000137	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—CD44—hematologic cancer	5.65e-06	0.000137	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—NQO1—hematologic cancer	5.65e-06	0.000137	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—MTHFR—hematologic cancer	5.6e-06	0.000136	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.59e-06	0.000136	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—GSTT1—hematologic cancer	5.58e-06	0.000135	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—SLC22A1—hematologic cancer	5.58e-06	0.000135	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CRABP1—hematologic cancer	5.58e-06	0.000135	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—IDH2—hematologic cancer	5.54e-06	0.000134	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—HMMR—hematologic cancer	5.54e-06	0.000134	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—GSTT1—hematologic cancer	5.53e-06	0.000134	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.53e-06	0.000134	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—SDC1—hematologic cancer	5.46e-06	0.000132	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—GSTP1—hematologic cancer	5.45e-06	0.000132	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.45e-06	0.000132	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ALOX5—hematologic cancer	5.44e-06	0.000132	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—SDC1—hematologic cancer	5.41e-06	0.000131	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.35e-06	0.00013	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—CYCS—hematologic cancer	5.35e-06	0.00013	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	5.31e-06	0.000129	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—NUP98—hematologic cancer	5.26e-06	0.000128	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ARNTL—hematologic cancer	5.2e-06	0.000126	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.17e-06	0.000125	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—ABCB1—hematologic cancer	5.16e-06	0.000125	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—NCOA3—hematologic cancer	5.11e-06	0.000124	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ADCY7—hematologic cancer	5.11e-06	0.000124	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.1e-06	0.000124	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—NUP214—hematologic cancer	5.07e-06	0.000123	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ACP5—hematologic cancer	5.06e-06	0.000123	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CA9—hematologic cancer	5.06e-06	0.000123	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—NQO1—hematologic cancer	5.04e-06	0.000122	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—CD44—hematologic cancer	5.04e-06	0.000122	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.02e-06	0.000122	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—NCOR1—hematologic cancer	5.01e-06	0.000122	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—GSTM1—hematologic cancer	5.01e-06	0.000122	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—NCOR2—hematologic cancer	5e-06	0.000121	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—MTR—hematologic cancer	4.97e-06	0.000121	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ABCG2—hematologic cancer	4.97e-06	0.000121	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.94e-06	0.00012	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.88e-06	0.000118	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ENO2—hematologic cancer	4.88e-06	0.000118	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.78e-06	0.000116	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—CYCS—hematologic cancer	4.77e-06	0.000116	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—IDH1—hematologic cancer	4.76e-06	0.000116	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	4.74e-06	0.000115	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—GSTT1—hematologic cancer	4.73e-06	0.000115	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—GSTP1—hematologic cancer	4.71e-06	0.000114	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PIK3CG—hematologic cancer	4.71e-06	0.000114	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—TXN—hematologic cancer	4.71e-06	0.000114	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ABCC3—hematologic cancer	4.71e-06	0.000114	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GSTO1—hematologic cancer	4.71e-06	0.000114	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.66e-06	0.000113	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CD44—hematologic cancer	4.64e-06	0.000113	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—NQO1—hematologic cancer	4.64e-06	0.000113	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—SDC1—hematologic cancer	4.62e-06	0.000112	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—SPHK1—hematologic cancer	4.61e-06	0.000112	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—NQO1—hematologic cancer	4.6e-06	0.000112	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CD44—hematologic cancer	4.6e-06	0.000112	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.56e-06	0.000111	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.5e-06	0.000109	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—ABCB1—hematologic cancer	4.46e-06	0.000108	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—MTHFR—hematologic cancer	4.43e-06	0.000107	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.43e-06	0.000107	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.42e-06	0.000107	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CYCS—hematologic cancer	4.39e-06	0.000107	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—CREBBP—hematologic cancer	4.37e-06	0.000106	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	4.36e-06	0.000106	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.36e-06	0.000106	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CYCS—hematologic cancer	4.35e-06	0.000106	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—NCOR1—hematologic cancer	4.33e-06	0.000105	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—GSTM1—hematologic cancer	4.33e-06	0.000105	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	4.32e-06	0.000105	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—SLC22A1—hematologic cancer	4.31e-06	0.000104	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CRABP1—hematologic cancer	4.31e-06	0.000104	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.27e-06	0.000104	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—GSTP1—hematologic cancer	4.21e-06	0.000102	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ALOX5—hematologic cancer	4.2e-06	0.000102	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.17e-06	0.000101	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PIK3CD—hematologic cancer	4.14e-06	0.0001	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—ALB—hematologic cancer	4.09e-06	9.91e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.07e-06	9.88e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—NUP98—hematologic cancer	4.06e-06	9.86e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—ABCB1—hematologic cancer	3.98e-06	9.66e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.94e-06	9.57e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.94e-06	9.57e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CD44—hematologic cancer	3.93e-06	9.54e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—NQO1—hematologic cancer	3.93e-06	9.54e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—NUP214—hematologic cancer	3.92e-06	9.5e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PIK3R1—hematologic cancer	3.91e-06	9.48e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.89e-06	9.44e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—GSTP1—hematologic cancer	3.87e-06	9.39e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—GSTM1—hematologic cancer	3.87e-06	9.38e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—NCOR1—hematologic cancer	3.87e-06	9.38e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.85e-06	9.34e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—MTR—hematologic cancer	3.84e-06	9.31e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.84e-06	9.31e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—GSTP1—hematologic cancer	3.84e-06	9.31e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—MTHFR—hematologic cancer	3.83e-06	9.29e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ENO2—hematologic cancer	3.76e-06	9.13e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PIK3CG—hematologic cancer	3.72e-06	9.03e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CYCS—hematologic cancer	3.72e-06	9.02e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.71e-06	9.01e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	3.7e-06	8.97e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—ABCB1—hematologic cancer	3.66e-06	8.89e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.65e-06	8.86e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—ABCB1—hematologic cancer	3.63e-06	8.81e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PIK3CB—hematologic cancer	3.61e-06	8.75e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—SDC1—hematologic cancer	3.57e-06	8.66e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—NCOR1—hematologic cancer	3.56e-06	8.63e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—GSTM1—hematologic cancer	3.56e-06	8.63e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—NCOR1—hematologic cancer	3.53e-06	8.55e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—GSTM1—hematologic cancer	3.53e-06	8.55e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—CREBBP—hematologic cancer	3.45e-06	8.37e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—MTHFR—hematologic cancer	3.42e-06	8.29e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.37e-06	8.19e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.33e-06	8.07e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—GSTP1—hematologic cancer	3.28e-06	7.95e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PIK3CD—hematologic cancer	3.27e-06	7.94e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—ALB—hematologic cancer	3.23e-06	7.84e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PIK3CG—hematologic cancer	3.22e-06	7.8e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.17e-06	7.7e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—MTHFR—hematologic cancer	3.14e-06	7.63e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PTEN—hematologic cancer	3.12e-06	7.56e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—MTHFR—hematologic cancer	3.12e-06	7.56e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ABCB1—hematologic cancer	3.1e-06	7.53e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PIK3R1—hematologic cancer	3.09e-06	7.49e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—NQO1—hematologic cancer	3.03e-06	7.36e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CD44—hematologic cancer	3.03e-06	7.36e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—GSTM1—hematologic cancer	3.01e-06	7.31e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—NCOR1—hematologic cancer	3.01e-06	7.31e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.01e-06	7.31e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—CREBBP—hematologic cancer	2.98e-06	7.24e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—EP300—hematologic cancer	2.97e-06	7.21e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PIK3CG—hematologic cancer	2.87e-06	6.97e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CYCS—hematologic cancer	2.87e-06	6.96e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.85e-06	6.92e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PIK3CB—hematologic cancer	2.85e-06	6.92e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PIK3CD—hematologic cancer	2.83e-06	6.86e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—ALB—hematologic cancer	2.79e-06	6.77e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.75e-06	6.66e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PIK3R1—hematologic cancer	2.67e-06	6.48e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.66e-06	6.46e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—CREBBP—hematologic cancer	2.66e-06	6.46e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.64e-06	6.41e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.62e-06	6.35e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.53e-06	6.14e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PIK3CD—hematologic cancer	2.52e-06	6.12e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—ALB—hematologic cancer	2.49e-06	6.04e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PIK3CB—hematologic cancer	2.46e-06	5.98e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PTEN—hematologic cancer	2.46e-06	5.98e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.45e-06	5.94e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.43e-06	5.89e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.39e-06	5.81e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PIK3R1—hematologic cancer	2.38e-06	5.78e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—EP300—hematologic cancer	2.35e-06	5.7e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.35e-06	5.69e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.32e-06	5.64e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.32e-06	5.64e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.32e-06	5.63e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.3e-06	5.58e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—ALB—hematologic cancer	2.29e-06	5.56e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—ALB—hematologic cancer	2.27e-06	5.51e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PIK3CG—hematologic cancer	2.24e-06	5.43e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PIK3CB—hematologic cancer	2.2e-06	5.34e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PIK3CA—hematologic cancer	2.2e-06	5.34e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.19e-06	5.32e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PIK3R1—hematologic cancer	2.17e-06	5.27e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PTEN—hematologic cancer	2.13e-06	5.17e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CREBBP—hematologic cancer	2.07e-06	5.03e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.05e-06	4.99e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—EP300—hematologic cancer	2.03e-06	4.93e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PIK3CB—hematologic cancer	2.02e-06	4.91e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PIK3CB—hematologic cancer	2.01e-06	4.87e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.97e-06	4.77e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ALB—hematologic cancer	1.94e-06	4.71e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PTEN—hematologic cancer	1.9e-06	4.61e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.86e-06	4.51e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—EP300—hematologic cancer	1.81e-06	4.4e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—AKT1—hematologic cancer	1.8e-06	4.36e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PTEN—hematologic cancer	1.75e-06	4.24e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PIK3CA—hematologic cancer	1.74e-06	4.22e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PTEN—hematologic cancer	1.73e-06	4.21e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.73e-06	4.19e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.71e-06	4.16e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—EP300—hematologic cancer	1.67e-06	4.05e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—EP300—hematologic cancer	1.65e-06	4.01e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.6e-06	3.88e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.52e-06	3.68e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.5e-06	3.65e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ALB—hematologic cancer	1.5e-06	3.64e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PTEN—hematologic cancer	1.48e-06	3.59e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.43e-06	3.48e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—AKT1—hematologic cancer	1.42e-06	3.45e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—EP300—hematologic cancer	1.41e-06	3.43e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.34e-06	3.25e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.32e-06	3.21e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.23e-06	2.99e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—AKT1—hematologic cancer	1.23e-06	2.98e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.22e-06	2.97e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PTEN—hematologic cancer	1.14e-06	2.77e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—AKT1—hematologic cancer	1.1e-06	2.66e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—EP300—hematologic cancer	1.09e-06	2.64e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.04e-06	2.54e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—AKT1—hematologic cancer	1.01e-06	2.44e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—AKT1—hematologic cancer	9.99e-07	2.42e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—AKT1—hematologic cancer	8.54e-07	2.07e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PIK3CA—hematologic cancer	8.06e-07	1.96e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—AKT1—hematologic cancer	6.59e-07	1.6e-05	CbGpPWpGaD
